Copy Link Print Information

Rimonabant

(Synonyms: SR141716)
16 Cited Publications
Revisión del cliente

Based on 16 publication(s) in Google Scholar

Rimonabant (SR141716) is a highly potent, brain penetrated and selective central cannabinoid receptor (CB1) antagonist with a Ki of 1.8 nM. Rimonabant (SR141716) also inhibits Mycobacterial membrane protein Large 3 (MMPL3).

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza : 99.52%
  • No. CAS: 168273-06-1
  • Fòrmula: C22H21Cl3N4O
  • Peso molecular:463.79
  • Almacenamiento:

    4°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Rimonabant Chemical Structure
    Rimonabant Chemical Structure
  • Experimental Validation Results for Rimonabant
  • Experimental Validation Results for Rimonabant
  • Experimental Validation Results for Rimonabant
  • Experimental Validation Results for Rimonabant
  • Experimental Validation Results for Rimonabant
No. CAS: 168273-06-1
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Rimonabant:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Protocolo
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Rimonabant

More
Customer Validation & Images
In Vivo Efficacy StudyBio/Physico-chemical AssayCell Proliferation/Viability Assay
  • In Vivo Efficacy Study
  • In Vivo Efficacy Study
  • Bio/Physico-chemical Assay
  • Cell Proliferation/Viability Assay
  • Bio/Physico-chemical Assay

Ver todos los productos específicos de isoformas Cannabinoid Receptor

More

Keywords

MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Rimonabant Chemical Structure
    Rimonabant Chemical Structure
    1/16
  • 1/16

    Rimonabant purchased from MedChemExpress. Usage Cited in: Cell. 2025 Dec 24;188(26):7547-7570.e45 [Abstract]

    Customer Validation
     FO of WT and CNR1 KO mice treated with Rimonabant (3 mg/kg; i.p.; single dose).

  • 1/16

    Rimonabant purchased from MedChemExpress. Usage Cited in: J Psychopharmacol. 2025 Jul 31:2698811251355603. [Abstract]

    Customer Validation
     AUClog of low- and high-impulsive subpopulations for each treatment condition (Vehicle pre-treatment, Vehicle post-treatment, and Rimonabant (1 mg/kg; once every other day for 3 consecutive doses)). The results showed that Rimonabant reversed WIN55212-2-induced elevation in AUClog in rats via antagonism of the CB1 receptor.

  • 1/16

    Rimonabant purchased from MedChemExpress. Usage Cited in: Int J Mol Sci. 2024 May 3;25(9):5012. [Abstract]

    Customer Validation
     Fluorescent signal of Rimonabant at inhibiting GRABeCB2.0 basal fluorescence as determined by averaging ΔF/F0 between 4 and 5 min. The results showed that Rimonabant suppressed the fluorescent signal to below baseline levels in stable HEK293 cells expressing the GRABeCB2.0 sensor, indicating inverse agonist activity (EC50= 42 nM).

  • 1/16

    Rimonabant purchased from MedChemExpress. Usage Cited in: Autophagy. 2021 Nov;17(11):3592-3606. [Abstract]

    Customer Validation
     Effect of various ion channel inhibitors on CBD-induced glioma cell death. U251 or LN18 cells were pretreated with Rimonabant (1 μM), SR144528 (1 μM), SEA0400 (10 μM), DIDS (10 μM), CID16020046 (1 μM), SKF96365 (1 μM), RuR (1 μM), mibefradil (2.5 uM), capsazepine (1 μM), or GSK2193874 (5 μM) for 1 h and then treated with CBD (30 μM) for 48 h. Cell viability was determined by the MTT assay. The results showed that Rimonabant failed to reverse the cell growth inhibitory effects induced by CBD.

  • 1/16

    Rimonabant purchased from MedChemExpress. Usage Cited in: Cell. 2019 Jan 24;176(3):636-648.e13. [Abstract]

    Customer Validation
     Rimonabant was found to bind to MmpL3 with a dissociation constant (Kd value) of 29 μM.

  • Rimonabant